Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardial Ischemia | 23 | 2017 | 2148 | 1.730 |
Why?
|
Hypercholesterolemia | 9 | 2012 | 1151 | 1.500 |
Why?
|
Stilbenes | 8 | 2013 | 156 | 1.250 |
Why?
|
Surgical Wound Dehiscence | 4 | 2023 | 215 | 1.060 |
Why?
|
Naproxen | 3 | 2011 | 99 | 0.880 |
Why?
|
Coronary Circulation | 10 | 2012 | 1572 | 0.760 |
Why?
|
Myocardium | 16 | 2020 | 4776 | 0.750 |
Why?
|
Sternotomy | 6 | 2023 | 121 | 0.710 |
Why?
|
Alcoholic Beverages | 5 | 2012 | 265 | 0.680 |
Why?
|
Wine | 5 | 2017 | 165 | 0.670 |
Why?
|
Collateral Circulation | 7 | 2012 | 287 | 0.660 |
Why?
|
Sternum | 4 | 2023 | 177 | 0.660 |
Why?
|
Swine | 31 | 2017 | 5917 | 0.660 |
Why?
|
Neovascularization, Physiologic | 10 | 2014 | 1351 | 0.650 |
Why?
|
Carbon Monoxide | 1 | 2021 | 531 | 0.640 |
Why?
|
Surgical Wound Infection | 4 | 2023 | 1540 | 0.590 |
Why?
|
Cardiopulmonary Bypass | 7 | 2022 | 1066 | 0.570 |
Why?
|
Oxidative Stress | 10 | 2020 | 3086 | 0.560 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2011 | 371 | 0.510 |
Why?
|
Sulfonamides | 4 | 2011 | 1938 | 0.470 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2011 | 476 | 0.440 |
Why?
|
Pyrazoles | 3 | 2011 | 1972 | 0.430 |
Why?
|
Swine, Miniature | 16 | 2014 | 961 | 0.420 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2011 | 320 | 0.420 |
Why?
|
Prostaglandins | 2 | 2011 | 405 | 0.390 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2013 | 3508 | 0.370 |
Why?
|
Apoptosis | 10 | 2020 | 9727 | 0.360 |
Why?
|
Warm Ischemia | 1 | 2010 | 53 | 0.360 |
Why?
|
Ethanol | 5 | 2017 | 1342 | 0.360 |
Why?
|
Heart | 4 | 2012 | 4467 | 0.330 |
Why?
|
Coronary Vessels | 7 | 2012 | 3107 | 0.310 |
Why?
|
Thrombin | 1 | 2010 | 598 | 0.310 |
Why?
|
Coronary Artery Disease | 8 | 2022 | 6487 | 0.310 |
Why?
|
Heptanoic Acids | 3 | 2014 | 343 | 0.310 |
Why?
|
Endothelium | 1 | 2010 | 778 | 0.310 |
Why?
|
Organ Preservation | 1 | 2010 | 331 | 0.300 |
Why?
|
Heart Arrest, Induced | 3 | 2013 | 355 | 0.290 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2012 | 282 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4034 | 0.270 |
Why?
|
Myocardial Revascularization | 3 | 2019 | 841 | 0.270 |
Why?
|
Arterioles | 5 | 2013 | 254 | 0.270 |
Why?
|
Heart Valve Prosthesis Implantation | 3 | 2023 | 1536 | 0.260 |
Why?
|
Disease Models, Animal | 21 | 2017 | 18029 | 0.250 |
Why?
|
Blood Proteins | 1 | 2010 | 1124 | 0.250 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2010 | 1116 | 0.230 |
Why?
|
Coronary Artery Bypass | 4 | 2022 | 2289 | 0.230 |
Why?
|
Immunoblotting | 5 | 2020 | 1682 | 0.230 |
Why?
|
Dietary Fats | 1 | 2011 | 2017 | 0.230 |
Why?
|
Pyrroles | 3 | 2014 | 1146 | 0.220 |
Why?
|
Diabetes Complications | 1 | 2010 | 1359 | 0.220 |
Why?
|
Aortic Valve Stenosis | 3 | 2023 | 1965 | 0.220 |
Why?
|
Cell Survival | 2 | 2010 | 5882 | 0.220 |
Why?
|
Energy Metabolism | 3 | 2012 | 2899 | 0.220 |
Why?
|
Debridement | 2 | 2022 | 492 | 0.220 |
Why?
|
Hemodynamics | 5 | 2012 | 4199 | 0.210 |
Why?
|
Mitral Valve Insufficiency | 2 | 2022 | 1422 | 0.200 |
Why?
|
Heart Valve Diseases | 2 | 2021 | 1073 | 0.200 |
Why?
|
Thromboxane A2 | 2 | 2011 | 92 | 0.200 |
Why?
|
Muscle, Skeletal | 6 | 2017 | 4931 | 0.200 |
Why?
|
Animals | 38 | 2021 | 168757 | 0.190 |
Why?
|
Cardiotonic Agents | 2 | 2014 | 535 | 0.190 |
Why?
|
Neuropeptide Y | 2 | 2012 | 200 | 0.190 |
Why?
|
RNA | 3 | 2020 | 2749 | 0.180 |
Why?
|
Microcirculation | 4 | 2012 | 1286 | 0.180 |
Why?
|
Embolectomy | 1 | 2020 | 120 | 0.170 |
Why?
|
Peptide Fragments | 2 | 2020 | 5097 | 0.170 |
Why?
|
Cardiac Surgical Procedures | 3 | 2022 | 3537 | 0.170 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2161 | 0.170 |
Why?
|
Perfusion | 4 | 2011 | 1360 | 0.170 |
Why?
|
Up-Regulation | 3 | 2020 | 4217 | 0.170 |
Why?
|
Random Allocation | 3 | 2017 | 2429 | 0.170 |
Why?
|
Receptors, Notch | 2 | 2014 | 739 | 0.170 |
Why?
|
Vena Cava Filters | 2 | 2020 | 252 | 0.160 |
Why?
|
Cyclooxygenase 2 | 2 | 2011 | 611 | 0.160 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2021 | 367 | 0.150 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2020 | 1354 | 0.150 |
Why?
|
Metformin | 3 | 2014 | 835 | 0.150 |
Why?
|
Signal Transduction | 11 | 2014 | 23403 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 458 | 0.150 |
Why?
|
Patient Care Team | 2 | 2020 | 2531 | 0.150 |
Why?
|
Myocardial Infarction | 4 | 2019 | 11727 | 0.150 |
Why?
|
Heart Diseases | 3 | 2018 | 2788 | 0.150 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2022 | 591 | 0.150 |
Why?
|
Endothelial Cells | 1 | 2010 | 3479 | 0.150 |
Why?
|
Intraoperative Care | 1 | 2021 | 767 | 0.150 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2019 | 272 | 0.140 |
Why?
|
Ventricular Function, Left | 5 | 2012 | 3670 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2022 | 1301 | 0.140 |
Why?
|
Pulmonary Embolism | 2 | 2020 | 2376 | 0.140 |
Why?
|
Muscle Contraction | 2 | 2011 | 1240 | 0.130 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2010 | 3336 | 0.130 |
Why?
|
Tricuspid Valve | 1 | 2018 | 403 | 0.130 |
Why?
|
Hospital Mortality | 2 | 2020 | 5317 | 0.130 |
Why?
|
Enzyme Induction | 2 | 2012 | 475 | 0.130 |
Why?
|
Thoracic Surgery | 1 | 2022 | 719 | 0.130 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2012 | 689 | 0.130 |
Why?
|
Thromboxanes | 2 | 2011 | 50 | 0.130 |
Why?
|
Insulin | 5 | 2012 | 6580 | 0.130 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2014 | 3255 | 0.120 |
Why?
|
Diabetes Mellitus | 3 | 2020 | 5751 | 0.120 |
Why?
|
Blotting, Western | 5 | 2017 | 5179 | 0.120 |
Why?
|
Male | 40 | 2023 | 350118 | 0.120 |
Why?
|
Lipid Peroxidation | 2 | 2012 | 270 | 0.120 |
Why?
|
Amyloidosis | 1 | 2021 | 795 | 0.120 |
Why?
|
Reference Values | 2 | 2011 | 4982 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2012 | 2109 | 0.120 |
Why?
|
Immunohistochemistry | 6 | 2017 | 11366 | 0.120 |
Why?
|
Sus scrofa | 2 | 2012 | 437 | 0.120 |
Why?
|
Heart Function Tests | 2 | 2011 | 330 | 0.120 |
Why?
|
Epoprostenol | 2 | 2011 | 254 | 0.110 |
Why?
|
Administration, Oral | 2 | 2011 | 3913 | 0.110 |
Why?
|
Hypoglycemic Agents | 4 | 2014 | 2872 | 0.110 |
Why?
|
Endothelium, Vascular | 4 | 2012 | 4456 | 0.110 |
Why?
|
Chemokines | 1 | 2017 | 970 | 0.110 |
Why?
|
Diet, Atherogenic | 1 | 2012 | 95 | 0.110 |
Why?
|
Interleukins | 1 | 2017 | 791 | 0.110 |
Why?
|
Oxygen | 2 | 2022 | 4189 | 0.110 |
Why?
|
Alcohols | 1 | 2012 | 92 | 0.110 |
Why?
|
Thrombectomy | 1 | 2017 | 680 | 0.110 |
Why?
|
Caspase 3 | 2 | 2014 | 758 | 0.100 |
Why?
|
Vasoconstriction | 2 | 2012 | 597 | 0.100 |
Why?
|
Sarcopenia | 1 | 2017 | 368 | 0.100 |
Why?
|
Chymases | 1 | 2011 | 99 | 0.100 |
Why?
|
Treatment Outcome | 11 | 2023 | 63114 | 0.100 |
Why?
|
Fractures, Bone | 1 | 2023 | 1947 | 0.100 |
Why?
|
Vasodilation | 2 | 2012 | 944 | 0.100 |
Why?
|
Humans | 38 | 2023 | 744343 | 0.100 |
Why?
|
Muscle, Smooth, Vascular | 3 | 2013 | 1504 | 0.100 |
Why?
|
Autophagy | 2 | 2020 | 1300 | 0.100 |
Why?
|
Gene Expression Regulation | 5 | 2018 | 12072 | 0.100 |
Why?
|
Vasoconstrictor Agents | 2 | 2011 | 642 | 0.100 |
Why?
|
Pericardium | 2 | 2012 | 667 | 0.090 |
Why?
|
Myocardial Reperfusion | 1 | 2011 | 351 | 0.090 |
Why?
|
Raffinose | 1 | 2010 | 52 | 0.090 |
Why?
|
Procaine | 1 | 2010 | 60 | 0.090 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2011 | 179 | 0.090 |
Why?
|
Potassium Chloride | 1 | 2010 | 237 | 0.090 |
Why?
|
Atrial Appendage | 1 | 2013 | 283 | 0.090 |
Why?
|
Organ Preservation Solutions | 1 | 2010 | 98 | 0.090 |
Why?
|
Female | 23 | 2023 | 380194 | 0.090 |
Why?
|
Blood Chemical Analysis | 1 | 2011 | 440 | 0.090 |
Why?
|
Mannitol | 1 | 2010 | 181 | 0.090 |
Why?
|
Coronary Angiography | 5 | 2012 | 4577 | 0.080 |
Why?
|
Phytotherapy | 1 | 2011 | 298 | 0.080 |
Why?
|
Endothelin-1 | 1 | 2010 | 314 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3870 | 0.080 |
Why?
|
Allopurinol | 1 | 2010 | 191 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14722 | 0.080 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2012 | 845 | 0.080 |
Why?
|
Mitral Valve | 3 | 2022 | 1491 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2010 | 489 | 0.080 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 430 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2012 | 2503 | 0.080 |
Why?
|
Hemorrhage | 1 | 2020 | 3461 | 0.080 |
Why?
|
Angiogenic Proteins | 3 | 2014 | 104 | 0.080 |
Why?
|
Cholesterol, Dietary | 3 | 2014 | 231 | 0.080 |
Why?
|
Plant Extracts | 1 | 2011 | 471 | 0.080 |
Why?
|
Sodium Chloride | 1 | 2010 | 625 | 0.080 |
Why?
|
Glutathione | 1 | 2010 | 589 | 0.070 |
Why?
|
Risk Factors | 6 | 2023 | 72290 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3528 | 0.070 |
Why?
|
Aged | 18 | 2022 | 163280 | 0.070 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 996 | 0.070 |
Why?
|
Erythrocyte Transfusion | 2 | 2022 | 565 | 0.070 |
Why?
|
Phosphorylation | 3 | 2012 | 8436 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7729 | 0.070 |
Why?
|
Liver | 2 | 2012 | 7474 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2010 | 1100 | 0.070 |
Why?
|
Myocardial Contraction | 1 | 2011 | 1585 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2023 | 77449 | 0.070 |
Why?
|
Renin-Angiotensin System | 1 | 2010 | 759 | 0.060 |
Why?
|
Cryopreservation | 1 | 2010 | 670 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2012 | 6365 | 0.060 |
Why?
|
Adenosine | 1 | 2010 | 825 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2282 | 0.060 |
Why?
|
Antioxidants | 1 | 2012 | 1663 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2011 | 832 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2014 | 2635 | 0.060 |
Why?
|
Heart Arrest | 1 | 2013 | 1470 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2014 | 3617 | 0.060 |
Why?
|
Vasodilator Agents | 3 | 2012 | 977 | 0.060 |
Why?
|
Microvessels | 3 | 2012 | 544 | 0.050 |
Why?
|
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2012 | 68 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6256 | 0.050 |
Why?
|
Anticoagulants | 1 | 2017 | 4599 | 0.050 |
Why?
|
Length of Stay | 3 | 2021 | 6309 | 0.050 |
Why?
|
Pectoralis Muscles | 1 | 2022 | 82 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2012 | 3864 | 0.050 |
Why?
|
Glucose Transporter Type 4 | 2 | 2012 | 250 | 0.050 |
Why?
|
Protein Kinase C-alpha | 2 | 2012 | 112 | 0.050 |
Why?
|
Aortic Valve | 2 | 2023 | 1922 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6489 | 0.050 |
Why?
|
Tissue Adhesions | 2 | 2012 | 235 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 9438 | 0.050 |
Why?
|
Fibrosis | 3 | 2012 | 2029 | 0.050 |
Why?
|
Medicare | 1 | 2018 | 6566 | 0.050 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2012 | 563 | 0.050 |
Why?
|
Lipids | 1 | 2011 | 3305 | 0.050 |
Why?
|
Papillary Muscles | 1 | 2021 | 203 | 0.050 |
Why?
|
Liver Function Tests | 2 | 2012 | 528 | 0.050 |
Why?
|
Middle Aged | 9 | 2022 | 213383 | 0.050 |
Why?
|
Cognition Disorders | 1 | 2014 | 4043 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2915 | 0.040 |
Why?
|
Plaque, Atherosclerotic | 1 | 2011 | 1519 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2012 | 3966 | 0.040 |
Why?
|
Time | 1 | 2021 | 542 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2013 | 11725 | 0.040 |
Why?
|
Cause of Death | 2 | 2020 | 3584 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.040 |
Why?
|
Independent Living | 1 | 2023 | 568 | 0.040 |
Why?
|
Suture Techniques | 1 | 2023 | 798 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20129 | 0.040 |
Why?
|
Thrombosis | 1 | 2011 | 2968 | 0.040 |
Why?
|
Glucose | 1 | 2010 | 4397 | 0.040 |
Why?
|
Inflammation | 3 | 2012 | 10638 | 0.040 |
Why?
|
Chronic Disease | 4 | 2014 | 9146 | 0.040 |
Why?
|
Macrophages | 1 | 2011 | 5655 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15165 | 0.040 |
Why?
|
Comorbidity | 1 | 2011 | 10388 | 0.040 |
Why?
|
Coronary Disease | 1 | 2011 | 6077 | 0.040 |
Why?
|
Echocardiography, Transesophageal | 1 | 2022 | 1133 | 0.030 |
Why?
|
Myocardial Perfusion Imaging | 2 | 2012 | 554 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2013 | 1676 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10397 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10943 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12788 | 0.030 |
Why?
|
Ventricular Remodeling | 1 | 2022 | 1224 | 0.030 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 581 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2018 | 822 | 0.030 |
Why?
|
Intracranial Hemorrhages | 1 | 2020 | 855 | 0.030 |
Why?
|
Thorax | 1 | 2017 | 547 | 0.030 |
Why?
|
Heart Ventricles | 2 | 2020 | 3821 | 0.030 |
Why?
|
bcl-2-Associated X Protein | 1 | 2014 | 295 | 0.030 |
Why?
|
Ischemia | 1 | 2022 | 1907 | 0.030 |
Why?
|
Cardioplegic Solutions | 1 | 2013 | 118 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1372 | 0.030 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 2012 | 16 | 0.030 |
Why?
|
Protein Kinase C-epsilon | 1 | 2012 | 43 | 0.030 |
Why?
|
Receptors, Neuropeptide Y | 1 | 2012 | 44 | 0.030 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2012 | 86 | 0.030 |
Why?
|
Nitroprusside | 1 | 2012 | 275 | 0.030 |
Why?
|
Reoperation | 2 | 2012 | 4201 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2017 | 608 | 0.030 |
Why?
|
Retinol-Binding Proteins, Plasma | 1 | 2012 | 93 | 0.030 |
Why?
|
Inflammation Mediators | 2 | 2012 | 1889 | 0.030 |
Why?
|
Glucose Transporter Type 1 | 1 | 2012 | 192 | 0.030 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2011 | 9 | 0.030 |
Why?
|
Thromboxane-A Synthase | 1 | 2011 | 34 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2017 | 1641 | 0.030 |
Why?
|
Aorta | 1 | 2019 | 2061 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2012 | 130 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2012 | 425 | 0.020 |
Why?
|
Substance P | 1 | 2012 | 335 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2013 | 813 | 0.020 |
Why?
|
PPAR alpha | 1 | 2012 | 197 | 0.020 |
Why?
|
Type C Phospholipases | 1 | 2011 | 292 | 0.020 |
Why?
|
Receptors, Endothelin | 1 | 2010 | 58 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2020 | 1239 | 0.020 |
Why?
|
Angiostatins | 1 | 2010 | 67 | 0.020 |
Why?
|
Capillaries | 1 | 2013 | 773 | 0.020 |
Why?
|
Muscle Cells | 1 | 2011 | 197 | 0.020 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 491 | 0.020 |
Why?
|
Coronary Artery Bypass, Off-Pump | 1 | 2010 | 63 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 402 | 0.020 |
Why?
|
Caspases | 1 | 2012 | 928 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 611 | 0.020 |
Why?
|
Leptin | 1 | 2017 | 1599 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 383 | 0.020 |
Why?
|
Species Specificity | 1 | 2013 | 2478 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2013 | 1081 | 0.020 |
Why?
|
Gene Expression | 2 | 2012 | 7799 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1157 | 0.020 |
Why?
|
Hematocrit | 1 | 2010 | 636 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2011 | 767 | 0.020 |
Why?
|
Sphingosine | 1 | 2010 | 307 | 0.020 |
Why?
|
Peptides, Cyclic | 1 | 2010 | 400 | 0.020 |
Why?
|
Tyrosine | 1 | 2012 | 1461 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1150 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2505 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2017 | 1848 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2012 | 1227 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.020 |
Why?
|
Echocardiography | 1 | 2020 | 5102 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1526 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.020 |
Why?
|
Ventricular Fibrillation | 1 | 2010 | 538 | 0.020 |
Why?
|
Body Temperature | 1 | 2010 | 777 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2021 | 12026 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 1613 | 0.020 |
Why?
|
Thiophenes | 1 | 2011 | 588 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40075 | 0.020 |
Why?
|
Patient Readmission | 1 | 2020 | 3114 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2011 | 906 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2187 | 0.020 |
Why?
|
Cadherins | 1 | 2010 | 907 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1782 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2011 | 1970 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3520 | 0.020 |
Why?
|
Protein Transport | 1 | 2011 | 1988 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2011 | 3701 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13408 | 0.020 |
Why?
|
Oligopeptides | 1 | 2010 | 1189 | 0.020 |
Why?
|
Arteries | 1 | 2010 | 1119 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8663 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1990 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2012 | 21746 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2699 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2012 | 2132 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4371 | 0.010 |
Why?
|
Collagen | 1 | 2012 | 2689 | 0.010 |
Why?
|
Regeneration | 1 | 2012 | 1485 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2148 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57776 | 0.010 |
Why?
|
Robotics | 1 | 2010 | 899 | 0.010 |
Why?
|
Piperidines | 1 | 2010 | 1602 | 0.010 |
Why?
|
Risk Assessment | 1 | 2023 | 23338 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2917 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3920 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1273 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29063 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2010 | 2046 | 0.010 |
Why?
|
Fibroblasts | 1 | 2011 | 4161 | 0.010 |
Why?
|
United States | 2 | 2019 | 69872 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8324 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2011 | 8301 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2010 | 2038 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 35421 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4026 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3778 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4091 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4420 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2011 | 3297 | 0.010 |
Why?
|
Risk | 1 | 2011 | 9687 | 0.010 |
Why?
|
Adult | 2 | 2022 | 214055 | 0.010 |
Why?
|
Disease Progression | 1 | 2014 | 13284 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2013 | 7880 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7322 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2011 | 10481 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8554 | 0.010 |
Why?
|
Rats | 1 | 2011 | 24260 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5535 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9583 | 0.010 |
Why?
|
Diet | 1 | 2011 | 7939 | 0.010 |
Why?
|
Mice | 1 | 2010 | 81183 | 0.000 |
Why?
|